WASHINGTON — A pharmaceutical company responsible for an important anti-HIV medication had donated 200,000 treatments of their drug to the Center for Disease Control and Prevention. The goal of the donation is treat uninsured Americans free of charge.
The manufacture of Truvada PrEP, Gilead Sciences, will be donating 2.4 million bottles over the next eleven years.
Need more of today’s positive news stories? Follow us on Facebook!
Please follow and like us: